Teva Pharmaceutical Industries Limited Sponsored ADR Stock

$17.72

0.92% today

NYSE, Sep 19, 05:17 pm CET

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Teva Pharmaceutical Industries Limited Sponsored ADR Stock price

$17.88

+10.09 129.53% 5Y

NYSE, Closing price Wed, Sep 18 2024

+0.03 0.17%

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$20.26b
Enterprise Value	$37.13b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	17.90
EV/Sales (TTM) EV/Sales	2.28
P/S ratio (TTM) P/S ratio	1.24
P/B ratio (TTM) P/B ratio	3.19
Revenue growth (TTM) Revenue growth	8.38%
Revenue (TTM) Revenue	$16.30b
EBIT (operating result TTM) EBIT	$3.51b
Free Cash Flow (TTM) Free Cash Flow	$2.07b
Cash position	$2.26b
EPS (TTM) EPS	$-0.39
P/E forward	20.95
P/S forward	1.25
EV/Sales forward	2.28
Short interest	2.13%

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Get Started for Free Today

Teva Pharmaceutical Industries Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

??

12 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

8x Buy

67%

4x Hold

33%

More details on Analyst Estimates Including Price Targets

12 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

Buy

67%

Hold

33%

Analyst Estimates with Stock Price Targets

Financial data from Teva Pharmaceutical Industries Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter Annually

Assets

Jun '24
Current assets	11,632 11,632
Cash	2,258 2,258
Claims	3,766 3,766
Inventories	3,927 3,927
Other current assets Other current assets Current assets	1,681 1,681

Fixed assets	29,706 29,706
Property, plant and equipment	5,931 5,931
Financial assets	- -
Intangible Assets	21,341 21,341
Other fixed assets Other assets Fixed assets	2,434 2,434


Total Assets	41,338 41,338

Liabilities

Jun '24
Equity	6,563 6,563

Debt capital	34,774 34,774
Current liabilities	13,037 13,037
Non-current liabilities	21,737 21,737


Total Capital	41,337 41,337

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Teva Pharmaceutical Industries Limited Sponsored ADR Stock News

Neutral

Seeking Alpha

●

about one hour ago

Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference (Transcript)

Teva Pharmaceuticals Industries Limited (NYSE:TEVA ) Bank of America Global Healthcare Conference September 18, 2024 3:15 AM ET Company Participants Richard Francis - President & CEO Conference Call Participants Jason Gerberry - BofA Securities Jason Gerberry Thank you, Richard, for joining us here at the BofA Global Healthcare Conference in London. My name is Jason Gerberry.

Neutral

GlobeNewsWire

●

8 days ago

Teva to Present at the Bank of America 2024 Global Healthcare Conference

TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Bank of America 2024 Global Healthcare Conference on Thursday, September 19, 2024. The presentation will begin at 8.15 A.M. British summer time (3.15 A.M. Eastern Time).

Positive

Reuters

●

9 days ago

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

Baltimore said on Tuesday that it has settled with Walgreens over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.

More Teva Pharmaceutical Industries Limited Sponsored ADR News

Company Profile

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Head office	Israel
CEO	Richard Francis
Employees	37,226
Founded	1901
Website	www.tevapharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now